Ignite Creation Date:
2025-12-24 @ 9:21 PM
Ignite Modification Date:
2025-12-25 @ 7:08 PM
Study NCT ID:
NCT07037004
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-09-23
First Post:
2025-06-13
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Adding a Live Biotherapeutic Product (CBM588) to Pembrolizumab for the Treatment of Renal Cell Cancer After Surgery
Sponsor:
City of Hope Medical Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2026-05-04
Start Date Type:
ESTIMATED
Primary Completion Date:
2027-05-04
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-05-04
Completion Date Type:
ESTIMATED
First Submit Date:
2025-06-13
First Submit QC Date:
None
Study First Post Date:
2025-06-25
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-18
Last Update Post Date:
2025-09-23
Last Update Post Date Type:
ESTIMATED